With Johnson & Johnson Deals, Berkeley's Aduro Biotech Gets New Chance To Prove Worth

Published: Jun 18, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The idea behind Aduro BioTech’s experimental cancer treatment—turning a dangerous food-borne bacterium into a Trojan horse against tumors—may seem startlingly new. But the project arose a dozen years ago, and incubated slowly in three different companies, before emerging this summer into a long-awaited splash of sunlight.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news